In recent months, UK health regulators have issued warnings about a rise in counterfeit and unlicensed weight-loss injections being sold through social media platforms, online marketplaces and even gyms. These products are often marketed as GLP-1 medications, such as Ozempic, Wegovy or Mounjaro, but are not authorised, regulated or medically prescribed.
As demand for GLP-1 medications increases, experts are raising concerns about safety, quality and misinformation surrounding these illegal products.
What Are Counterfeit GLP-1 Injections?
GLP-1 receptor agonists are prescription-only medicines approved for managing type 2 diabetes and, in some cases, obesity. Counterfeit versions may:
-
Contain incorrect or unknown ingredients
-
Be manufactured without sterile conditions
-
Use inaccurate dosing or labelling
-
Be sold without medical screening or follow-up
UK regulators stress that these products are not the same as regulated prescriptions supplied through pharmacies or licensed providers.
Where Are These Products Being Sold?
Investigations have linked counterfeit weight-loss jabs to:
-
Instagram, TikTok and Telegram sellers
-
Private messaging groups
-
Online resale websites
-
Some gym and wellness communities
Many listings use phrases like “same as Ozempic,” “no prescription needed,” or “doctor-grade,” despite having no regulatory approval.
Why Health Authorities Are Concerned
The Medicines and Healthcare products Regulatory Agency (MHRA) has warned that counterfeit injectable medicines can carry serious risks, including:
-
Infection due to poor sterility
-
Incorrect dosing leading to adverse effects
-
Exposure to undeclared substances
-
Delayed diagnosis or treatment of underlying health conditions
Because these injections bypass medical oversight, users may not receive appropriate screening, guidance or monitoring.
How to Identify Legitimate GLP-1 Treatment
In the UK, approved GLP-1 medications are:
-
Prescription-only
-
Supplied by registered pharmacies or licensed clinics
-
Accompanied by medical assessment and follow-up
-
Clearly labelled with batch numbers and manufacturer details
Any product sold without these safeguards should raise immediate concern.
The Bigger Picture - Demand, Access and Misinformation
Experts suggest the rise in counterfeit products reflects a wider issue, high demand, limited access and confusion around weight-loss medications. Public health bodies continue to emphasise that medication should sit alongside appropriate nutrition, lifestyle support and professional care, rather than being sourced informally.
What UK Authorities Advise
Regulators recommend that individuals:
-
Avoid purchasing injectable medicines via social media or gyms
-
Speak to a GP or registered healthcare provider about weight-management options
-
Report suspected counterfeit medicines to the MHRA
-
Be cautious of “quick fix” claims or pressure-selling tactics
As investigations continue, authorities are working to remove illegal listings and educate consumers on the risks.
References
-
Medicines and Healthcare products Regulatory Agency (MHRA), UK safety alerts on counterfeit medicines
-
NHS England guidance on GLP-1 receptor agonists
-
BBC News & The Guardian reporting on illegal weight-loss injections
-
World Health Organization (WHO): Substandard and falsified medical products
